Underlying the plan are three 'Brexit Principles', devised by the College and formally adopted by RCVS Council, which will guide the College’s relationship with the Government during the forthcoming Brexit negotiations.
The College says each Principle is supported by a number of specific policies that the College will lobby for in the coming months, all designed to positively engage with the post-referendum reality and with government policy.
The Principles are:
RCVS Chief Executive Nick Stace said: "It is crucially important for the College and the profession as a whole to think boldly about the post-Brexit future; we cannot expect government to give us all of the answers, instead we must work to find solutions ourselves so as to shape the future of the profession from within."
The College has also asked the Institute for Employment Studies (IES) to undertake research into the attitudes and intentions of all EU-graduated veterinary surgeons and veterinary nurses currently working in the UK. They will all have receive a personalised email from IES with a link to this online survey, and their answers will help inform the College’s approach to Brexit. This research will help the College to understand better the impact that Brexit may already be having, how it can support EU veterinary professionals working in the UK, and build an evidence base regarding the potential impact that Brexit may have on the veterinary workforce.
For more information on the College’s Brexit activities, visit: www.rcvs.org.uk/brexit
The new GPCert programme, led by course director Owen Davies MA VetMB MVetMed MANZCVS (Small Animal Medicine) DipACVIM (Oncology) (pictured right), consists of 12 modules covering key clinical subjects in veterinary oncology delivered over 14 months.
Each module consists of nine lessons, two case studies, course notes and weekly summary videos.
Lessons are supported by notes and videos, quizzes and a forum tutored by leading specialists.
Owen said: “Half of all canine cancers are treatable if caught early enough and new treatments are continuously being researched.
"The programme will guide delegates through the latest knowledge in state-of-the-art, compassionate cancer care for animals, helping them to provide safe and comprehensive diagnostics and treatments.”
For more information, visit: https://www.improveinternational.com/uk/course/oncology-online-learning/
The initiative comes after BEVA's new nurse committee ran a survey which found a poor understanding within the profession and amongst clients of what equine nurses can do.
Nurses said they believed they could be given more responsibility and do more within their roles and that there was a lack of opportunity for progression.
BEVA President David Rendle, who is championing this initiative, said: “RVNs are a significant an asset to any equine practice.
“They have invested a lot of time and effort to become highly skilled but in some instances their significant attributes are not being utilised to the full.
“Allowing RVNs to perform the clinical tasks that they are qualified to carry out under Schedule 3 of the Veterinary Surgeons Act 1966, will provide better job fulfilment and career development as well as free up veterinary surgeons to carry out other tasks, all increasing the efficiency of the veterinary team.
“I feel, and the RVN survey results would seem to confirm, that veterinary surgeons and practice managers do not appreciate how much veterinary nurses are allowed to do in equine practice.
"We all know veterinary nurses have the ability; look at what they do in small animal and human nursing, but we have felt unnecessarily constrained by Schedule 3 of the Veterinary Surgeons Act 1966 and the associated RCVS guidelines.
"If you actually look at Schedule 3 it is clear that we can and should be letting our qualified equine nurses do far more.
“There are so many things in equine practice that nurses do better than vets.
"In addition to performing clinical tasks they can add wider value; they are generally (or are perceived by clients to be!) more patient, empathetic and caring so we should utilise these skills and get nurses to take on some of the roles that take more time and require longer client interactions – discussing parasite control programmes, running weight loss clinics, reviewing healthcare plans, making follow-up phone calls and visits to name just a few.
"Nurses can take a lot of pressure off vets and can add a significant revenue stream for the practice.”
On the 9th February, the BEVA will be hosting an online discussion forum for all members of the practice team to discuss the role of nurses and how their skills, experience and knowledge can be better-used.
It's free for BEVA members: https://www.beva.org.uk/Home/Events/BEVA-Events/Event-Details.aspx?eventDateId=1716
Marie Rippingale Chair of the BEVA Nurse Committee said: “Last year’s recruitment and retention survey revealed that 50% of nurse respondents were earning less than £25,000 per annum and 48% of nurses said they were likely to look for a new job in the next two years.
"When asked their top reasons for leaving, salary was the biggest reason, and common themes on what would help the retention of nurses included salary, work-life balance and career progression.
“The review of Schedule 3 is important so we can encourage delegation of tasks to RVNs.
"This will allow RVNs to demonstrate their value and worth, earning money for the practice and achieving job satisfaction at the same time. This will contribute positively towards the current retention crisis.”
To find out more about what equine veterinary nurses can do in practice visit https://www.beva.org.uk/nurses
Photo: Liphook Equine Hospital.
A new expert panel has been formed to evaluate pain management in canine osteoarthritis following a recent shift to a more integrated approach to pain and disease research.
In the past, pain and joint disease have been considered as separate areas of research, with pain perceived simply as a consequence of disease. Over the last few years, however, it has become increasingly apparent that the relationship is far more complex and that pain may be a driver of disease rather than just a consequence of it. The expert panel hopes to apply the new knowledge to the management of joint pain in veterinary practice.
The panel, which had its inaugural meeting in Paris recently, brings together acknowledged veterinary experts in the fields of pain and joint disease. Its focus will be on the assessment and management of pain in canine osteoarthritis (OA), with the objective of educating veterinary surgeons to better understand and manage pain in canine OA and thereby improve the well-being of pets that suffer from this common disease.
'Central sensitisation' is one of the latest theories that has been suggested to explain the complex interaction between pain and disease progression in canine OA. Duncan Lascelles, Associate Professor of Surgery at North Carolina State University, said that research has shown that the components of the pain pathway can change in response to a pain stimulus. Pain receptors 'up-regulate' in response to painful stimuli and become more sensitive to subsequent pain.
CNS sensitisation is likely a significant contributor to chronic or maladaptive pain; this pain leads to decreased mobility, reduced muscle support and reduced muscle function, thus leading to disease progression. In other words, joint diseases cause pain, which in turn feeds back to create more disease.
Professor Lascelles said: "The link between the clinical signs associated with OA and joint pathology is not a simple one and may be much more complex than we have previously thought.
"There is some evidence that COX inhibition reduces central sensitisation. And some evidence suggests that reducing central sensitisation may have a modulatory effect on disease progression by reducing signals going out to the periphery.
"The relationship between pain and disease progression is a very new area of research, and is at the forefront of our knowledge of how pain and joint disease are linked."
Professor John Innes, Head of Division, Small Animal Studies, University of Liverpool Veterinary School, told the meeting that OA is likely to be one of the major reasons for euthanasia of pet dogs in Europe. He and two co-investigators have performed a systematic review of the published evidence for the use of long-term, continuous NSAID treatment (at least 28 days) in OA. They found that this form of management is associated with better outcomes than short-term NSAID therapy, with no evidence of additional safety issues. This review is to be published shortly.
The expert panel comprises:
Prof Dr Stuart Carmichael, Vets Now Ltd. Formerly at: Veterinary School, University of Glasgow, UKProf Dr John Innes, Small Animal Teaching Hospital, University of Liverpool, UKDr Bernard Bouvy-Centre, Hospitalier Vétérinaire de Frégis, Arcueil, FranceProf Dr Jean-Pierre Genevois, Ecole Nationale Vétérinaire de Lyon, FranceDr Carlos Macías, Centro Veterinario de Referencia Bahia de Malaga, SpainProf Dr Martin Kramer, Klinik für Kleintiere, Chirurgie , Justus-Liebig-Universität Gießen, GermanyDr Sabine Tacke, Klinik für Kleintiere, Chirurgie, Justus-Liebig-Universität GießenProf Dr Duncan Lascelles, North Carolina State University College of Veterinary Medicine, Raleigh, USAProf Dr Herman A.W. Hazewinkel, Faculteit Diergeneeskunde, Departement Gezelschapsdieren, Utrecht, NetherlandsDr Emilio Feltri, Anaesthetist and specialist in Pain Management, Ambulatorio Veterinario Associato, Tortona, ItalyDr Peter Vandekerckhove, Specialist Surgeon Companion Animal, Wondelgem, Belgium
Woodley Equipment Company has become the exclusive Europe-wide distributor for the new Epoc Hand Held Clinical Care Analyser from Epocal Inc
Woodley says the Epoc, developed by the founder of the i-STAT analyser, is the first wireless point of care testing solution to use smart card technology. The Epoc provides immediate blood gas, electrolyte and critical care biochemistry results directly to a hand held PDA (included) and wirelessly interfaces with your in-practice computer. It is a completely affordable analyser that is easy to use and requires no refrigeration of consumables.
Key Features:
For a more information about the Epoc Blood Gas Analyser please email sales@woodleyequipment.com, visit woodleyequipment.com, or call Woodley's customer service team on +44 (0)1204 669033 ~ Option 1
45% of British pet owners believe their four legged friends share their human emotions and can sense when they are upset or unwell, according to a new survey announced by Bayer Animal Health.
The 'Pets are Human Too' study of 3,000 British dog and cat owners was commissioned by the company to celebrate Drontal's www.mypetsuperstar.com competition.
According to the study:
TV vet and My Pet Superstar Judge Emma Milne, said: "The joy and companionship our pets bring to our lives is unquestionable and it is no wonder that many consider them to be 'man's best friend'. Britain is a nation of proud pet owners and now, with the launch of My Pet Superstar, we all have a chance to show them off!"
Wiley has announced the joint online publication of a special issue of 22 ophthalmology papers from Equine Veterinary Journal, Equine Veterinary Education and Veterinary Ophthalmology.
Clinical equine ophthalmology: The current state of the art brings together papers on some of the most significant advances in equine clinical ophthalmology into a single issue to make them more readily available to a wider audience. The issue contains information of direct relevance to all sectors of the veterinary profession from general practitioners and specialists to researchers, surgeons and students, covering common diseases, surgical procedures and outcomes.
The new publication was devised and compiled by a panel of guest editors comprising Mary Lassaline, member of the Veterinary Ophthalmology Editorial board and Veterinary Ophthalmologist in the Department of Surgical and Radiological Sciences at UC-Davis School of Veterinary Medicine, California, David A. Wilkie, Editor of Veterinary Ophthalmology and Professor at Veterinary Clinical Sciences Comparative Ophthalmology Ohio State University, Tim Mair, Editor of Equine Veterinary Education based at Bell Equine Veterinary Clinic, Kent and Celia M Marr, Editor of Equine Veterinary Journal, based at Rossdales, Newmarket.Mary Lassaline said: "The goal was to provide broad access to the most current information applicable to every stratum of the equine veterinary profession. Subsequently, a salient feature is that many of the papers included are collaborations between veterinary ophthalmologists with a special interest in horses, equine practitioners with a special interest in ophthalmology, private practitioners and those in academia, and academicians from different institutions."
Subjects covered include seven papers on new approaches to the diagnosis and treatment of ulcerative and non-ulcerative keratitis in the horse. There are three articles on novel approaches to corneal surgery and a further three on corneal neoplasia. Six papers provide valuable data regarding long-term outcomes following surgical intervention for Equine Recurrent Uveitis (ERU), glaucoma, and cataracts. Finally, three articles present new information regarding retinal and orbital disease.
Professor Celia Marr, Editor of the Equine Veterinary Journal said: "The key purpose of the EVJ is to disseminate information to help the enhancement of specialist knowledge at every level of the veterinary profession. By collating the most important and up-to-date ophthalmology research into one easy resource the new special issue does exactly that."The ophthalmology special issue is available free online at: http://bit.ly/1bi0RG0
CM Research has announced the results of a survey conducted this month in which veterinary surgeons named Osurnia as the best new product of 2015.
290 companion animal veterinary surgeons took part in the survey, which is designed to provide veterinary surgeons with their peers’ unbiased judgement on which new veterinary products, services or devices have made the biggest impact on the industry.
The questions were unprompted to ensure that the respondents were not influenced by pre-set survey options. CM Research points to the fact that many of the products that featured in its rankings were launched before 2015, including 2nd and 3rd placed Apoquel and Bravecto, as evidence of this freedom.
The full list of products named more than once in this year's survey was:
Product
Manufacturer
Number of mentions
% of mentions
Osurnia
Elanco
67
23%
Apoquel
Zoetis
58
20%
Bravecto
MSD
29
10%
Semintra
Boehringer Ingelheim (BI)
13
4%
Amodip
Ceva
10
3%
Nexgard Spectra
Merial
8
Broadline
6
2%
UpCard
Vetoquinol
Zodon
5
Metabolic Diet
Hill's
4
1%
Nexgard
SDMA Test
IDEXX
Comfortis
3
Remend
Bayer
Seresto
Yumove
Lintbells
Bovela
BI
2
Comfortan
Dechra
Hill's y/d diet
Nutraquin
Nutravet
Pexion
Prinovox
Virbac
Pronefra
Thiafeline
Animalcare
Veraflox
Vetigel
Suneris
Cardalis
The hands-on course, which is worth 7 CPD hours, has been organised by Dr Nicola M Parry, Recognised Specialist in Pathology at the University of Surrey School of Veterinary Medicine. It will combine lectures, practicals, and a Q&A session to enable delegates to carry out a post-mortem, identify common (and not so common) pathologies, and draw conclusions about the cause of death.
The morning lectures will provide an overview of techniques that focus on how to approach the post-mortem examination of the adult horse and the foetus/foal, as well as how to examine the placenta. Potential findings will be discussed as well as some pitfalls to avoid during the post-mortem examination, and how to optimise sample submission. The lectures will be recorded, enabling sessions to be reviewed later.
Delegates will spend the afternoon in the post-mortem room, examining macroscopic specimens and learning practical approaches to a post-mortem examination in the field, and the collection of key specimens. The day will close with a Q&A session.
Speakers Dr Fabio Del Piero from the Louisiana State University and Dr Marvin J Firth from the University of Surrey will help delegates to:
Sarah Gaspar, the Learning Manager at BEVA said: “If you have ever been called out to a dead horse to find a distraught owner and not been sure how to identify the cause, this course is for you. We can’t remember any course ever having been run on this topic in the UK before; it is likely to be very popular so be quick to book.”
To find out more and to book click here: https://www.beva.org.uk/Education/CPD/Event-Details/eventDateId/1582
The results of a new study1 highlighting the prevalence of Angiostrongylus vasorum infection as seen by UK veterinary surgeons, combined with the low awareness amongst dog owners of this parasite2 has led Bayer Animal Health to launch a nationwide 'Be Lungworm Aware' initiative.
Backed by a hard-hitting national advertising, PR and radio campaign which kicks off in April, the initiative aims to highlight the prevalence of this potentially, and often fatal infection, and to drive pet owners to their veterinary practices for further information.
The initiative also sees the launch of a new educational website for dog owners - http://www.lungworm.co.uk/. The site offers further information on the infection, including likely signs, how to obtain treatment and a video of the lifecycle of the parasite showing the threat posed by the lungworm's intermediate hosts - slugs and snails.
The study revealed that 16% of vets questioned had one or more confirmed cases of the disease. A further 10% had seen dogs that they suspected had the infection. However, only 6% of dog owners questioned in a UK wide survey had unprompted awareness of the parasite.
Bayer's Chris White said: "These results are no surprise following the reports last year of confirmed cases of Angiostrongylus vasorum as far north as Glasgow. The disease has seen a rapid rise in importance over the past few years highlighted by the number of vets and nurses that attended the Advocate CPD meetings held around the country at the end of last year.
"The 'Be Lungworm Aware' initiative aims to educate owners on the risks associated with infection, to encourage them to visit their vet for further information and discuss their dogs' parasite protection plan."
For further details, or to order the supporting practice materials, including a new educational waiting room display and practice PR pack to help raise awareness locally, please contact your Bayer representative or ring 01635 563682.
1Insight Track, 2008 2Insight Track, 2009
The College’s PDP is a period of structured self-assessment, reflection and development designed to help veterinary graduates in the transition from life as a veterinary student to clinical practice.
During the PDP (which normally lasts no more than three years after the graduate enters clinical practice), graduates are supported by a Postgraduate Dean and are expected to keep a record of their clinical cases against a list of clinical skills and procedures, and reflect on how they are progressing in relation to the PDP Competences.
In 2016 BSAVA launched its online PDP Resource Bank, matched to the RCVS competences and created to provide BSAVA graduate members with CPD support during their first years in practice.
The research project, which is being conducted across the whole profession, aims to:
The RCVS and the BSAVA have now appointed the Work Psychology Group, to undertake the research. The research team also includes Professor Susan Rhind, from the Royal (Dick) School of Veterinary Studies, University of Edinburgh, and Professor Liz Mossop of the School of Veterinary Medicine and Science, University of Nottingham.
Christine Warman, Director of Education at the RCVS, said: "Since its launch in 2007 the PDP has had some success in helping graduates in the transition into practice life, but we recognise that there is some frustration and uncertainty with the process and that not everyone finds it helpful.
"So we are very pleased to be joining forces with the BSAVA on this project and hope it will help us get a better sense of how both graduates and employers feel about the PDP, where obstacles to learning and development exist, potential gaps in support provision and common areas of confusion, anxiety and concern."
Sheldon Middleton, BSAVA Honorary Treasurer and board sponsor of the BSAVA’s PDP Resource, said: "BSAVA recognised the gap in provision of support material for the professional skills element of the PDP and created the PDP Resource Bank to plug this gap for our members. We worked with the RCVS to match the resources to the structure of the PDP but also recognised that there was a need for support for employers of new graduates as well. The PDP Resource Bank is growing and has a dedicated editorial board reviewing material for inclusion. This research project will allow us to tailor our resource further and ensure our members are able to access the support they need.”
The research will be conducted across the whole veterinary profession through focus groups and telephone interviews and will include graduates, employers, vet school representatives, Postgraduate Deans, and BSAVA and British Veterinary Association (BVA) representatives. The results of the research will ultimately be made publicly available across the profession, together with recommendations for the further development of the PDP.
For more information about the PDP, visit www.rcvs.org.uk/pdp. You can find the BSAVA’s PDP Resource Bank at https://www.bsava.com/Education/PDP
NDSR’s director of neurology Rodolfo Capello said: "This technology is one of the most advanced in medicine and helps to surgically remove tumours while also reducing the tissue damage to vital structures.
"The accuracy and control of the system offers us greater versatility and precision, and minimises invasive manoeuvres during both soft and hard tissue dissections.
"Surgeons can therefore be extremely confident of accurate tumour excision with reduced blood vessel and tissue damage which will all help increase and improve the outcome of our surgeries.
"We’ll be using the ultrasonic surgical aspirator for the removal of tumours in the brain, liver and to cut through bone where necessary. It will be a great asset."
For more information, visit: www.ndsr.co.uk
The centre, which is one of the largest animal hospitals in the UK, offers 14 specialist-led services.
Hospital director Daniel Hogan said: “The new hospital will provide the region with one of the largest and best-equipped veterinary centres in not only the UK, but also throughout Europe, with an extensive range of expertise in a wide variety of disciplines all under one roof.
“There will be seven operating theatres, 16 consultation rooms, recovery suites, lecture halls, a dedicated ICU department and there are plans for a future hydrotherapy suite.
“The facilities also include a cutting-edge imaging suite, comprehensive treatment facilities and a new linear accelerator to assist our illustrious oncology team.
"We also plan to launch our emergency and critical care service in the first half of 2023.”
Southfields says it also aims to lead the industry in terms of staff wellbeing and sustainability.
Daniel said: “The increased size of the hospital will enable us to provide a dedicated staff wellbeing area and offer a range of activities which will benefit our team in both body and mind.
“Along with exercise and relaxation classes such as yoga and boxercise, we will have an education centre which will be able to offer some really exciting qualifications and courses for the wider profession.
“We’ll also be striving to care for both our community by working with Investors in the Environment (iiE) to introduce a bold green initiative to substantially reduce our environmental impact and enhance our sustainability.
https://southfields.co.uk/veterinary-professionals/new-hospital
To help veterinary practices engage with pet owners and help them understand the importance of eye health, TVM has produced a range of free educational materials including waiting room displays, informative web pages and social media packs.
The company has also published a page of information at www.tvm-uk.com/eyehealth – where pet owners can find out more about eye problems, how to spot them and learn what can be done about them.
Emma Hancox MRCVS, Veterinary Advisor at TVM said: "It can be easy for owners to miss the signs of problems with their pet’s eyes, but they can be extremely distressing for animals and be a sign of conditions ranging from cataracts and glaucoma through to conjunctivitis - all of which can be painful, and in the worst-case scenario, lead to blindness.
"We hope that National Pet Eye Health Awareness Week will help practices assist owners in understanding the importance of eye health and prevent more serious conditions occurring."
To request your board kit and pet owner leaflets, and download your free social media pack, visit www.tvm-uk.com/eyehealth or contact your Territory Manager.
For practices planning to take part in National Microchipping Month, Virbac is providing a personalised poster design service and chip promotion throughout June.
According to product manager Gillian Brown, the idea is to offer additional tailored support to practices during the promotional period: "Obviously many practices will have National Microchipping Month materials in place, but the price each practice offers their clients is individual to them. These posters provide a visual platform to highlight the promotion.
"To take advantage of the scheme, practices just need to notify their territory manager of the price they propose to charge and we will then manage the design and print."
Virbac will also be offering a promotional chip price in June to support National Microchipping Month. Gillian said: "Microchipping is now the official means of pet identification approved by the EU Pet Passport Scheme. This will help practices provide an attractive promotion to pet owners and hopefully encourage greater up-take of microchipping."
Any practice interested in the initiative should contact their local Virbac territory manager or call Virbac on 01379 243243.
Jon Bowen, animal behaviour consultant at the Royal Veterinary College and Sureflap have declared 8th May 'Vet Cat Watch Day', and are asking the profession to record the reason why each cat seen that day is brought into the practice.
Jon explained: "There are more than 10 million pet cats in the UK, however there is little information about the prevalence of injuries, disease, cat fights and road traffic accidents on a national scale".
The absence of data became apparent when findings from research on over 1,000 cats - conducted as part of the Neighbourhood Cat Campaign, supported by SureFlap and Your Cat magazine - revealed cats that had suffered minor injuries from fights were more likely to develop other health issues, such as hair loss and eye infections.
Judith Bank from SureFlap said: "People often purchase a microchip-operated cat flap to help their pet to feel secure. Owners tell us that their pet is spraying in the house or has been losing fur and this motivated us to support research to look deeper into the problems that pet owners might be having. We soon realised that objective data from vets was not available to qualify the findings and this is where the idea of 'Vet Cat Watch Day' emerged."
Jon said: "The aim of Vet Cat Watch Day is to take a snap-shot of cats' health from veterinary practices across the nation, on one day. The results will be compiled alongside information from cat owners gained in 'Cat Watch Day' a few days earlier.
A report detailing preliminary findings from the Neighbourhood Cat Campaign is available from the SureFlap website. When complete the results will be used to help provide vets with an insight into the lives of domestic cats so they are better equipped to understand behavioural issues.
For more information on Vet Cat Watch Day please visit the SureFlap website The site hosts a PDF to print out and help record the feline cases that come through practice doors on the 8th May, which can be downloaded from www.sureflap.co.uk/vetwatch_info. At the end of the day, visit www.sureflap.co.uk/vetwatch to upload your data to the online survey.
The Association says it delayed this decision as late as possible, and whilst the most recent government advice does not prohibit large public gatherings, it recognises the importance of personal safety for Congress attendees and the need to support the profession in preserving business continuity, maintaining client services and protecting animal welfare.
Amanda Stranack, BSAVA CEO, said: "As the situation continues to escalate, the government have given a clear steer that they expect more stringent controls to come into force in the coming weeks. With Congress now only a few weeks away, we want to give all our attendees as much notice as possible, both to ensure peace of mind, and to give people adequate time and flexibility to change their plans.
"BSAVA recognises the pressures the current situation brings to bear on the veterinary community and in making this difficult decision, has the interests of the profession first and foremost in its mind.
"We would thank all those who have worked hard over the past two years to contribute to the development of Congress, a huge amount of effort goes into preparations from BSAVA volunteers, Congress participants and our staff."
Sue Paterson, BSAVA President, said: "It is with great regret that we have made the difficult decision to cancel Congress, which has taken place annually for more than 60 years. Congress is an incredibly important event in the veterinary calendar, and we were all looking forward to an inspiring agenda and saying a fond farewell to the city that has made Congress such a great success over so many years. The health and wellbeing of our attendees is of utmost importance to us, and whilst we are sorry to be making this decision, we are confident it is the right one."
BSAVA says it is aware of the impact that cancelling will have on many delegates' CPD hours, so it is now looking at other ways it can deliver Congress lectures and podcasts.
Sue added: "Whilst we won’t be able to deliver the full Congress programme, we will be working with our speakers to capture as many lectures as we can to make content available online."
The company points to an increasing trend across Europe towards feeding raw diets to pets, with 4% of UK cats and 10% of UK dogs now being fed raw meat and animal by-products.
The webinar, which will also look at the role of testing, offers an opportunity to learn more about the pathogens and parasites associated with raw feeding and the role of the right test at the right time.
Horiba says it's not just pets that need testing, but the raw materials used in their food.
Ian, who is Head of ESCCAP (the European Scientific Council for Companion Animal Parasites) UK & Ireland, said: “The recent trend of increasing raw feeding opens up new opportunities for pathogen transmission.
"Where raw feeding is taking place, adequate tapeworm and protozoal parasite prevention is essential to reduce zoonotic risk and economic losses.
“Testing forms an essential part of their control, and understanding this role and the diagnostic test options available will prove valuable to all veterinary professionals.”
Following Ian's presentation, there will be an open Q&A session.
Horiba’s team of veterinary specialists will also be available at the end of the webinar to discuss and advise on any testing needs, including its veterinary PCR system, the POCKIT Central.
To register, visit: https://register.gotowebinar.com/register/4306408134214190348
Dechra Veterinary Products has produced a pair of presentations, aimed at pet owners, for vets to use in receptions and at client events. The presentations cover canine hyperadrenocorticism, aka Cushing's syndrome, and feline hyperthyroidism.
Matthew Olsen, Product Manager, said: "We are committed to delivering a wide range of support materials and tools to enable vets to provide help and information to their customers. We have developed an owners' booklet on both Cushing's and hyperthyroidism and have now backed this up with PowerPoint presentations for vets to use with their clients. Some veterinary practices are using technology to revolutionise waiting room displays and we have responded to their needs by producing a presentation they can use on their waiting room information screens."
The Dechra Hyperadrenocorticism presentation covers what Cushing's is, what causes it and what owners need to look for. The presentation also explains the treatment options available. The Hyperthyroidism presentation details what the condition is and gives information on the thyroid gland. It highlights what cat owners need to look out for, including weight loss in spite of a ravenous appetite, increased fluid intake and increased restlessness. The presentation also advises people of what to do should they suspect their cat has hyperthyroidism and what the treatment options are.
Garden Lodge Veterinary Clinic in Holywood, County Down, has used the Hyperthyroidism presentation at both its practices. Partner Tom Fitzsimons said: "We have used the presentation on our reception information screens. The presentation has raised owners' awareness and shown them it is a manageable condition. It's led to an increase in the number of cats we are now testing for Hyperthyrodism. We also plan to run the Cushing's presentation in the future."
Veterinary Practices interested in getting hold of a free copy of the Hyperthyrodism and Hyperadrenocorticism presentations should contact Matthew Olsen at Dechra on 01743 441 632 or email matthew.olsen@dechra.com
Dechra Veterinary Products has launched Rycarfa carprofen tablets for dogs and injection for cats and dogs into its Veterinary Essentials range.
Dechra's Veterinary Essentials range comprises a series of post patent products designed to offer practices the reassurance of proven, quality solutions to meet their everyday clinical needs.
In its flavoured tablet form, Rycarfa is presented in easy-to-dispense blister packs which, according to Dechra, offer the most cost-effective standard size range on the market* - 20 mg x 100 tabs; 50 mg x 100 tabs, 50 mg x 500 tabs, 100mg x 100 tabs. The tablets are licensed in dogs for the reduction of inflammation and pain caused by musculoskeletal disorders and degenerative joint disease, and as a follow up to parenteral analgesia in the management of post operative pain.
In injection form, Rycarfa is provided as a 50mg/ml solution in a 20 ml glass vial. In dogs it is indicated for the control of post-operative pain and inflammation following orthopaedic and soft tissue (including intraocular) surgery. In cats, it is indicated for the control of post-operative pain following surgery.
Roger Brown at Dechra said: "Carprofen is a well-established, non-steroidal anti-inflammatory. Through our Veterinary Essentials range, we are offering Rycarfa in a wide range of sizes to provide the maximum flexibility with cost effectiveness."
For further information on Rycarfa, please contact Dechra on 01939 211200.
*Gfk sales data 1 July 2011
The materials are designed to help educate pet owners on the benefits of microchipping and the importance of keeping their microchip details up to date.
The company highlights research which shows just how important it is to encourage owners to keep microchip details up to date. In 2017, the BVA found that 44% of vets were unable to reunite stray dogs with their owners due to incorrect information on the microchip database. The Dogs Trust Stray Dogs Survey Report 2017–18 also found that 75% of all microchipped dogs that were unable to be returned to their owners had incorrect contact information on their chip.
To order your 'Chip & Check' display, contact your Animalcare Territory Sales Manager, or call Animalcare's head office on 01904 487687. Display packs are subject to an order of identichip microchips and while display stocks last.
The European Commission has agreed with the BSAVA and BVA that controls must be maintained to keep the UK free from the tapeworm Echinococcus multilocularis, and adopted a regulation that will permit pre-movement treatment for dogs travelling to listed Member States (i.e. the UK, Ireland, Finland and Malta).
In June Defra announced that the UK's derogation from European pet travel rules, which allows additional protection for the UK against rabies, ticks and tapeworms, would end on 31 December 2011. The movement rules on rabies and ticks will now be harmonised with the rest of Europe.
However, due to the significant public health risk posed by Echinococcus multilocularis, the BVA and BSAVA (working with Defra, the Federation of Veterinarians of Europe [FVE] and colleagues in Veterinary Ireland) continued to lobby the European Commission for controls on tapeworms to be maintained.
The regulation will ensure that a dog must be treated by a veterinary surgeon 24 to 120 hours (1-5 days) before entering one of the listed countries.
The BVA and BSAVA say they made a scientific case for a treatment window of 24-48 hours, but accept that the Commission had to find a compromise that would assist pet owners travelling during national holidays.
Harvey Locke, President of the BVA said: "This has been a long process but the BVA and BSAVA put forward the strong scientific case for the UK to maintain tapeworm controls and we are delighted that the European Commission has adopted this resolution.
"In our role as guardians of public health, vets were deeply concerned that the removal of tapeworm controls would see the introduction of EM to the UK and Ireland.
"Although relatively benign in dogs, the resulting disease in humans - alveolar echinococcosis - is an invasive, cancer-like cystic stage of the parasite, and is invariably fatal if not treated.
"The next stage of our lobbying will be to ensure that Member States and MEPs from across Europe support the UK's case for the additional controls."
Andrew Ash, President of BSAVA said: "Echinococcus multilocularis is a significant public health threat and we have worked hard to ensure the European Commission understands the potential impact of allowing this zoonotic disease to enter our country.
"The BVA and BSAVA will continue to promote the best possible health and welfare advice for pet owners taking their animals abroad. Our advice to owners is to speak to a vet as early as possible to make sure pets are protected from all diseases and parasites encountered abroad."
Vetoquinol - makers of the NSAID Cimalgex - has announced the launch of its updated website www.CiMyDog.co.uk.
The company says the website has been developed to provide reliable online information about pain in dogs to cater for the increasing needs of pet owners and vets.
The website has two sections. The first is a pet owner focussed, educational tool which takes the visitor on a journey through the process of pain; from spotting the signs of pain all the way through to ways of relieving pain, culminating in the recommendation that the visitor seeks advice from their veterinary practice.
The second section requires registration as it contains more in depth information on the pain process and potential treatment options available, this section is for veterinary professionals only. Also on this section of the website there are many scientific abstracts related to pain and treatment with links to enable the veterinary visitor can view this peer reviewed material.
Robert Simpson, Cimalgex Product Manager said: "The internet is a very powerful tool in terms of increasing education, especially in areas such as canine pain. Unfortunately there can also be a lot of misinformation online and so we felt it was important for Vetoquinol to try and redress the balance by producing www.CiMyDog.co.uk. This can be used as a reliable and up-to-date resource by pet owners and veterinary professionals alike. -
www.CiMyDog.co.uk is a very interactive site which aims to demystify the pain treatment process, ensure pet owners look out for behavioural signs of pain and looks to improve overall canine health with assistance from their veterinary practice. We hope that this will be a valuable resource to which vets can refer their pet owners."
Petplan is running its television advertising campaign from now until October.
The advert (below) is airing on Sky 1, Sky Atlantic, ITV2, ITV3, More 4, Gold and USA.
Suzanne Cheadle, Acting Head of Marketing at Petplan said: "As the UK market leader, it is imperative that pet owners recognise and understand who we are and what we stand for. We need to help pet owners understand not only why pet insurance is so important, but explain why they should choose Petplan over any other provider. In 36 years, there's not an illness or accident that we haven't seen, and our Covered For Life policies have been developed with unrivalled knowledge and experience."
Ceva Animal Health has launched Hepaticare, a new liver support supplement for cats and dogs.
The company says Hepaticare contains the same high quality ingredients as Hepatosyl, but is now enhanced with micro-encapsulated SAMe to enhance product stability and patient acceptance.
Hepaticare contains the antioxidants of S-adenosylmethionine (SAMe), vitamin E and silybin to help maintain liver function, and vitamin K to support the normal blood clotting process. Ceva says these ingredients help neutralise damaging free radicals produced by the liver during times of stress, while the SAMe has been micro-encapsulated to enhance stability, reduce any bitter aftertaste and increase patient acceptance.
Hepaticare capsules can be given whole or opened and sprinkled onto, or mixed with, food.
Rob McLintock, companion animal business unit manager at Ceva Animal Health, said: “Following a change in supplier we have taken the opportunity to launch a new liver support supplement, ensuring that the new and improved product, Hepaticare, is as effective and as easy to administer as possible.”
Hepaticare pack sizes and pricing will remain the same as for Ceva’s Hepatosyl. Until the end of September, Hepaticare will be available on a buy one get one free offer.
For further information, contact your local Ceva territory manager or phone 01494 781510.